Cambridge, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a biotechnology platform designed to develop tools for large-scale analysis of genetic variations and gene function. Enhanced Genomics is based in Cambridge, United Kingdom and was founded in 2020. Its last reported valuation was $28.1 million in Sep 2025. It has raised $21.8 million.
Last reported valuation
$28.1M
Oct 2026
Priced at
—
Total raised
$21.8M
Last round
—
Cap table — not yet on record
Enhanced Genomics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enhanced Genomics with a free account
·Watch Enhanced Genomics: the Monday email on marks, rounds and moves
